
Clinical Applications
Articles
-
Jan 15, 2025 |
ccforum.biomedcentral.com | Clinical Applications
This study involved the analysis of prospective cohorts of adult patients with sepsis (n = 53) or septic shock (n = 63) and healthy controls (n = 50) from Zhongda Hospital, as well as pediatric septic patients (n = 88) or septic shock patients (n = 18) and healthy controls (n = 90) from the Children’s Hospital of Nanjing Medical University.
-
Dec 4, 2024 |
ophthalmologyscience.org | Clinical Applications |Cameron Duic |Emily Y. Chew |Catherine Cukras
Keywordsage-related macular degenerationartificial intelligencespectral-domain optical coherence tomographyHeidelberg SpectralisZeiss Cirrusgeneralizabilityretinal pigment epithelium drusen complextotal retinal volumesdrusenmachine learningretinal image analysis1 IntroductionSpectral-domain optical coherence tomography (SD-OCT) images are commonly used for the diagnosis and monitoring of outer retinal diseases, such as age-related macular degeneration (AMD) [1], [2], [3].
-
Sep 6, 2024 |
ondrugdelivery.com | Chaoyoung Lee |Mike Stout |Clinical Applications
Citation: Lee C, Stout M, “Designing a More Versatile and Modern Wearable Device”. ONdrugDelivery, Issue 164 (Sep 2024), pp 24–27. Chaoyoung Lee and Mike Stout introduce the Horizon wearable micro-pump platform, a cutting-edge advancement in the drug delivery device market that marks a significant contribution to wearable drug-device design.
Increasing concentrations of intravitreal therapies for neovascular age-related macular degeneration
Mar 7, 2024 |
thelancet.com | Emily Y. Chew |Clinical Applications
Age-related macular degeneration (AMD), a leading cause of blindness, is projected to affect 288 million people globally in 2040 from an estimate of 196 million in 2020.The vision-threatening late forms of the disease include neovascular AMD (nAMD) and geographical atrophy.
-
Aug 9, 2023 |
ophthalmologyscience.org | Emily Y. Chew |Clinical Applications |Leanne T. Labriola
Several patient-reported outcome measures (PROMs) are available to measure health-related quality of life (HRQoL) in patients with late stage clinical diabetic retinal diseases (DRD). However, an understanding of the psychometric properties of PROMs is needed to assess how they could relate to severity levels of a revised DRD grading system. This narrative review assesses the available generic-, vision- and DRD-related PROMs used in DRD research and highlights areas for improvement.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →